Singapore-based SynPhNe has collaborated with life sciences commercialisation company Indegene to launch its Synergistic Physio-Neuro Platform into the market.
SynPhNe has created a new connected wearable solution, which is claimed to be a first-of-its-kind device that trains the brain and the muscles in one system.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The non-invasive, connected health solution aims to aid stroke survivors and disabled patients in their recovery process, enabling them to lead more independent lives and empowering them to perform daily activities.
Indegene emerging biotech and key accounts senior vice-president Timothy Moore said: “We will use our modern go-to-market model to drive pricing strategy and develop a strategic launch plan that coordinates education and marketing efforts based on our deep expertise in market research and brand planning.”
With a decade of clinical research supporting its efficacy, this device offers an array of care programmes designed to address issues related to the rehabilitation and recovery of patients suffering from neurological conditions.
These conditions include stroke and traumatic brain injuries, learning disabilities, chronic stress, ageing-related issues and pain.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSynPhNe leverages an advanced neuroplasticity training model that facilitates the recovery of body-and-brain function.
A self-correcting learning loop is established by capturing synchronised electroencephalography and electromyography signals in real time during tasks and activities.
This enables individuals to independently engage in physical therapy, occupational therapy and neuro therapy protocols at home, following initial training with a therapist.
SynPhNe Health president Sabi Bivas said: “More people are being impacted by neurological conditions each year.
“To help them get better access to effective treatment, we are excited to work with Indegene to bring our treatment option to the market. Indegene’s focus on technology and providing future-ready healthcare aligns with our mission.”
